Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 107620
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107620
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107620
Table 1 Web servers available for predicting Cytotoxic T Lymphocyte, Helper T lymphocyte, and B-cell epitopes
Web server | Prediction methods | Website link | Ref. |
Cytotoxic T lymphocyte epitope | |||
NetCTL 1.2 | Uses an ANN approach to combine MHC class I peptide binding, proteasomal C-terminal cleavage, and TAP transport efficiency | https://services.healthtech.dtu.dk/services/NetCTL-1.2/ | Larsen et al[69], 2007 |
NetMHCpan 4.1 | Predicts peptide binding to MHC molecules based on quantitative binding affinity and eluted ligands identified by mass spectrometry, using an ANN approach | https://services.healthtech.dtu.dk/services/NetMHCpan-4.1/ | Reynisson et al[70], 2020 |
CTLPred | Predicts CTL epitopes based on T cell epitope patterns, utilizing both ANN and SVM approaches | http://crdd.osdd.net/raghava/ctlpred/ | Bhasin and Raghava[71], 2004 |
Helper T lymphocyte epitope | |||
NetMHCIIpan 4.0 | Predicts peptide binding to MHC II molecules (HLA-DR, HLA-DQ, HLA-DP) based on binding affinity and eluted ligands identified by mass spectrometry, using an ANN approach | https://services.healthtech.dtu.dk/services/NetMHCIIpan-4.0/ | Reynisson et al[70], 2020 |
ProPred | Predicts MHC Class II (HLA-DR) binding regions within antigen sequences using QM | http://crdd.osdd.net/raghava/propred/ | Singh and Raghava[72], 2001 |
MARIA | Predicts the likelihood of antigen presentation from a specific gene related to HLA class II alleles, using peptide sequences from mass spectrometry, antigen gene expression levels, and protease cleavage patterns with an ANN approach | https://maria.stanford.edu/ | Chen et al[73], 2019 |
Linear B Cell epitope | |||
ABCpred | Uses an RNN approach that considers peptide length to predict B cell epitopes within antigen sequences | http://crdd.osdd.net/raghava/abcpred/ | Saha and Raghava[114], 2006 |
Bepipred Linear Epitope Prediction 2.0 | Uses a random forest algorithm trained on annotated epitopes from antibody-antigen protein structures | https://services.healthtech.dtu.dk/services/BepiPred-2.0/ | Jespersen et al[115], 2017 |
BCEPS | Predicts linear B cell epitopes using an SVM approach based on the tertiary structure of antibody-antigen complexes | http://imbio.med.ucm.es/bceps/ | Ras-Carmona et al[116], 2021 |
SEMA | Applies a transfer learning approach using a pre-trained deep learning model to predict conformational B cell epitopes based on primary antigen sequences and tertiary structures | https://sema.airi.net/ | Shashkova et al[117], 2022 |
LBtope | Uses SVM and Ibk approaches on a large dataset of experimentally validated B cell epitopes and non-epitopes to predict linear B cell epitopes | https://webs.iiitd.edu.in/raghava/lbtope/index.php | Singh et al[118], 2013 |
Bcepred | Predicts B cell epitopes using physicochemical properties, such as hydrophilicity, flexibility, accessibility, polarity, exposed surface, and turns | http://crdd.osdd.net/raghava/bcepred/ | Saha and Raghava[77], 2004 |
COBEpro | Uses an SVM to predict short peptide fragments within query antigen sequences, calculating an epitope propensity score for each residue | https://scratch.proteomics.ics.uci.edu/ | Sweredoski and Baldi[119], 2009 |
CLBTope | Combines alignment-based and alignment-free machine learning methods to predict B cell epitopes, using epitope and non-epitope sequence composition | https://webs.iiitd.edu.in/raghava/clbtope/ | Kumar et al[120], 2024 |
- Citation: Naully PG, Tan MI, El Khobar KE, Sukowati CHC, Giri-Rachman EA. Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics. World J Hepatol 2025; 17(7): 107620
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/107620.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.107620